Cama Patel, MD - Medicare Family Practice in Bridgeport, CT

Cama Patel, MD is a medicare enrolled "Family Medicine" physician in Bridgeport, Connecticut. She graduated from medical school in 1996 and has 28 years of diverse experience with area of expertise as Family Practice. She is a member of the group practice St. Vincents Urgent Care Llc and her current practice location is 4600 Main St, Bridgeport, Connecticut. You can reach out to her office (for appointments etc.) via phone at (203) 371-4445.

Cama Patel is licensed to practice in Connecticut (license number 47536) and she also participates in the medicare program. She may accept medicare assignments (which means she may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and her NPI Number is 1740207364.

Contact Information

Cama Patel, MD
4600 Main St,
Bridgeport, CT 06606-1839
(203) 371-4445
Not Available



Physician's Profile

Full NameCama Patel
GenderFemale
SpecialityFamily Practice
Experience28 Years
Location4600 Main St, Bridgeport, Connecticut
Accepts Medicare AssignmentsMay be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Cama Patel graduated from medical school in 1996
  NPI Data:
  • NPI Number: 1740207364
  • Provider Enumeration Date: 07/17/2006
  • Last Update Date: 11/26/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 4183512114
  • Enrollment ID: I20100503000432

Medical Identifiers

Medical identifiers for Cama Patel such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740207364NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 47536 (Connecticut)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
St. Vincents Urgent Care Llc690111976728

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Cama Patel allows following entities to bill medicare on her behalf.
Entity NameSt. Vincent's Multispecialty Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043544489
PECOS PAC ID: 6204977218
Enrollment ID: O20100112000538

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Entity NameQuentin Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487087250
PECOS PAC ID: 4981833647
Enrollment ID: O20140130000098

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Entity NameSt. Vincents Urgent Care Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912305483
PECOS PAC ID: 6901119767
Enrollment ID: O20150722005148

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Entity NameQmg 2 Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437546363
PECOS PAC ID: 0345541512
Enrollment ID: O20151211000754

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Entity NameQmg4 Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023471299
PECOS PAC ID: 4284912957
Enrollment ID: O20161031002469

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Entity NameQmg3 Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1053856039
PECOS PAC ID: 8628353117
Enrollment ID: O20170324000321

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Cama Patel is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Cama Patel, MD
2800 Main St,
Bridgeport, CT 06606-4201

Ph: (203) 576-6133
Cama Patel, MD
4600 Main St,
Bridgeport, CT 06606-1839

Ph: (203) 371-4445

News Archive

Immediate behavioral intervention effective in reducing PTSD

Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.

Leica receives FDA Pre-Market Approval for new HER2 IHC test

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products.

IQWiG dossier assessment finds no added benefit of lixisenatide

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care examined whether this new drug offers an added benefit over the current standard therapy.

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

UVA earns national award for video detailing efforts to improve quality of care for children with asthma

For a video detailing efforts to improve the quality of care for children with asthma, University of Virginia Health System has earned a national award from the Robert Wood Johnson Foundation (RWJF).

Read more News

› Verified 4 days ago


Family Medicine Doctors in Bridgeport, CT

Dr. Frank Raymond Scifo, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 2800 Main St, Bridgeport, CT 06606
Phone: 203-576-5986    Fax: 203-576-6020
Dr. John P Iannarone, MD
Family Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 4600 Main St, Bridgeport, CT 06606
Phone: 203-371-4445    
Pierre Hubert Estime, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 46 Albion St, Bridgeport, CT 06605
Phone: 203-330-6000    Fax: 203-330-6007
Laura Belland, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 267 Grant St, Bridgeport, CT 06610
Phone: 203-384-3000    
Dr. Maria Mikolaenko, DO
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 2979 Main St, Bridgeport, CT 06606
Phone: 203-382-2345    Fax: 203-366-0868
Dennis Williams, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1381 Reservoir Ave, Bridgeport, CT 06606
Phone: 203-371-5197    Fax: 203-371-6118
David F Altamirano, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2800 Main St, Bridgeport, CT 06606
Phone: 203-576-6000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.